Literature DB >> 28369442

CD40-CD40L cross-talk drives fascin expression in dendritic cells for efficient antigen presentation to CD4+ T cells.

Diana M Elizondo1, Temesgen E Andargie1, Dineeta S Kubhar1, Ayele Gugssa1, Michael W Lipscomb1.   

Abstract

Fascin is an actin-bundling protein that, among immune cells, is restricted to expression in dendritic cells (DCs). Previous reports have suggested that fascin plays an important role in governing DC antigen presentation to CD4+ T cells. However, no report has clearly linked the receptor-ligand engagement that can direct downstream regulation of fascin expression. In this study, bone marrow-derived DCs from wild-type versus CD40-knockout C57BL/6 mice were used to elucidate the mechanisms of fascin expression and activity upon CD40-CD40 ligand (CD40L) engagement. These investigations now show that CD40 engagement governs fascin expression in DCs to promote CD4+ T-cell cytokine production. Absence of CD40 signaling resulted in diminished fascin expression in DCs and was associated with impaired CD4+ T-cell responses. Furthermore, the study found that loss of CD40-CD40L engagement resulted in reduced DC-T-cell contacts. Rescue by ectopic fascin expression in CD40-deficient DCs was able to re-establish sustained contacts with T cells and restore cytokine production. Taken together, these results show that cross-talk through CD40-CD40L signaling drives elevated fascin expression in DCs to support acquisition of full T-cell responses. © The Japanese Society for Immunology. 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  actin bundling; co-receptor; co-stimulation; cytoskeleton; immune synapse

Mesh:

Substances:

Year:  2017        PMID: 28369442      PMCID: PMC5421612          DOI: 10.1093/intimm/dxx013

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  53 in total

1.  The immunological synapse: a molecular machine controlling T cell activation.

Authors:  A Grakoui; S K Bromley; C Sumen; M M Davis; A S Shaw; P M Allen; M L Dustin
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

2.  Cutting edge: dendritic cell actin cytoskeletal polarization during immunological synapse formation is highly antigen-dependent.

Authors:  Monther M Al-Alwan; Robert S Liwski; S M Mansour Haeryfar; William H Baldridge; David W Hoskin; Geoffrey Rowden; Kenneth A West
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

3.  Requirement of Rac1 and Rac2 expression by mature dendritic cells for T cell priming.

Authors:  Federica Benvenuti; Stephanie Hugues; Marita Walmsley; Sandra Ruf; Luc Fetler; Michel Popoff; Victor L J Tybulewicz; Sebastian Amigorena
Journal:  Science       Date:  2004-08-20       Impact factor: 47.728

Review 4.  Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application.

Authors:  B Thurner; C Röder; D Dieckmann; M Heuer; M Kruse; A Glaser; P Keikavoussi; E Kämpgen; A Bender; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

5.  Mechanisms for segregating T cell receptor and adhesion molecules during immunological synapse formation in Jurkat T cells.

Authors:  Yoshihisa Kaizuka; Adam D Douglass; Rajat Varma; Michael L Dustin; Ronald D Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

Review 6.  Cell adhesion molecules and actin cytoskeleton at immune synapses and kinapses.

Authors:  Michael L Dustin
Journal:  Curr Opin Cell Biol       Date:  2007-10-17       Impact factor: 8.382

7.  Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.

Authors:  A I Jaiswal; C Dubey; S L Swain; M Croft
Journal:  Int Immunol       Date:  1996-02       Impact factor: 4.823

8.  Phosphorylation of human fascin inhibits its actin binding and bundling activities.

Authors:  Y Yamakita; S Ono; F Matsumura; S Yamashiro
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

Review 9.  The cellular context of T cell signaling.

Authors:  Michael L Dustin
Journal:  Immunity       Date:  2009-04-17       Impact factor: 31.745

10.  Altered actin centripetal retrograde flow in physically restricted immunological synapses.

Authors:  Cheng-han Yu; Hung-jen Wu; Yoshihisa Kaizuka; Ronald D Vale; Jay T Groves
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

View more
  5 in total

1.  Inhibitors of the Actin-Bundling Protein Fascin-1 Developed for Tumor Therapy Attenuate the T-Cell Stimulatory Properties of Dendritic Cells.

Authors:  Yanira Zeyn; Gregory Harms; Ingrid Tubbe; Evelyn Montermann; Nadine Röhrig; Maike Hartmann; Stephan Grabbe; Matthias Bros
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

2.  Antithymocyte Globulin Antibody Titer Congruent With Kidney Transplantation: Analysis of Incidence, Outcomes, Cost, and Alternative Targets.

Authors:  Sherene Lattimore; Nicholas J Skill; Mary A Maluccio; Holly Elliott; Elizabeth Dobben; Asif Shafuddin; William C Goggins
Journal:  Transplant Direct       Date:  2019-09-27

3.  Alternative NF-κB Signaling Discriminates Induction of the Tumor Marker Fascin by the Viral Oncoproteins Tax-1 and Tax-2 of Human T-Cell Leukemia Viruses.

Authors:  Stefanie Heym; Caroline F Mohr; Hanna C Engelbrecht; Bernhard Fleckenstein; Andrea K Thoma-Kress
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

4.  Interactions between dendritic cells and T lymphocytes in pathogenesis of nasal polyps.

Authors:  Xinsheng Lin; Xiayan Zhuang; Chuangwei Li; Xin Wang
Journal:  Exp Ther Med       Date:  2018-05-03       Impact factor: 2.447

5.  Genomic, proteomic, and immunologic associations with a durable complete remission of measurable metastatic melanoma induced by a patient-specific dendritic cell vaccine.

Authors:  Robert O Dillman; Gabriel I Nistor; Aleksandra J Poole
Journal:  Hum Vaccin Immunother       Date:  2019-11-15       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.